Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NERV Minerva Neurosciences

盘前交易 04-09 06:06:55 EDT

5.42

+0.24

+4.63%

最高5.48	最低5.16	成交量34.29万
今开5.29	昨收5.18	日振幅6.18%
总市值2.35亿	流通市值2,947万	总股本4,327万
成交额183.45万	换手率6.31%	流通股本543.70万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NERV","market":"US","secType":"STK","nameCN":"Minerva Neurosciences","latestPrice":5.42,"timestamp":1775678400000,"preClose":5.18,"halted":0,"volume":342939,"delay":0,"changeRate":0.04633204633204638,"floatShares":5437017,"shares":43274398,"eps":-34.67,"marketStatus":"盘前交易","change":0.24,"latestTime":"04-09 06:06:55 EDT","open":5.29,"high":5.48,"low":5.16,"amount":1834495.3009,"amplitude":0.061776,"askPrice":7.54,"askSize":100,"bidPrice":5.35,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-34.67,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775741400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1404187200000,"exchange":"NASDAQ","adjPreClose":5.42,"postHourTrading":{"tag":"盘后","latestPrice":5.42,"preClose":5.42,"latestTime":"16:10 EDT","volume":2708,"amount":14677.36,"timestamp":1775679004142,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.883882973484358,"impliedVol":4.114,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NERV","defaultTab":"news","newsList":[{"id":"1187770397","title":"Minerva Neurosciences宣布全球三期确证性试验完成首例患者筛选，评估Roluperidone治疗精神分裂症阴性症状","url":"https://stock-news.laohu8.com/highlight/detail?id=1187770397","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187770397?lang=zh_cn&edition=full","pubTime":"2026-04-01 04:06","pubTimestamp":1774987584,"startTime":"0","endTime":"0","summary":"生物制药公司Minerva Neurosciences近日披露，其针对精神分裂症阴性症状的创新疗法Roluperidone已启动全球三期确证性临床试验，并成功完成首例患者筛选。该试验旨在进一步验证Roluperidone对改善患者社交退缩、情感淡漠等核心阴性症状的疗效与安全性。此次进展标志着该药物在应对精神分裂症未满足临床需求方面迈出关键一步，为后续申报上市奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102941713","title":"Minerva Neurosciences 计划通过多次发行募集高达2亿美元证券","url":"https://stock-news.laohu8.com/highlight/detail?id=1102941713","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102941713?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:23","pubTimestamp":1773235420,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）的一份最新文件披露，生物制药公司 Minerva Neurosciences Inc. 可能通过多次证券发行，筹集最高达2亿美元的资金。这一举措旨在为公司的运营和研发活动提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614851150","title":"Minerva Neurosciences, Inc盘中异动 股价大跌6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614851150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614851150?lang=zh_cn&edition=full","pubTime":"2026-02-25 03:26","pubTimestamp":1771961173,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日03时26分，Minerva Neurosciences, Inc股票出现波动，股价急速跳水6.57%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Edesa Biotech, Inc.、Palvella Therapeutics, Inc.涨幅较大，Edesa Biotech, Inc.、Biorestorative Therapies, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为976.61%、851.28%、603.23%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Edesa Biotech, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为599.00%、96.77%、54.12%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022503261397a6e4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022503261397a6e4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610626535","title":"Minerva Neurosciences, Inc盘中异动 早盘大幅上涨6.25%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610626535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610626535?lang=zh_cn&edition=full","pubTime":"2026-02-09 23:14","pubTimestamp":1770650071,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日23时14分，Minerva Neurosciences, Inc股票出现波动，股价大幅拉升6.25%。截至发稿，该股报5.10美元/股，成交量1.8585万股，换手率0.04%，振幅8.12%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Liminatus Pharma, Inc.、Lunai Bioworks Inc.、Humacyte, Inc.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为141.48%、48.34%、23.35%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Moolec Science Sa C/Wts 30/01/2028、Genenta Science Spa，振幅分别为34.95%、33.80%、28.39%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209231431a6e6aad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209231431a6e6aad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601079548","title":"Minerva Neurosciences, Inc盘中异动 早盘快速拉升5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601079548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601079548?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:53","pubTimestamp":1767797627,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时53分，Minerva Neurosciences, Inc股票出现波动，股价快速拉升5.69%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为2.01%。其相关个股中，Monte Rosa Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Ventyx Biosciences, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Aspire Biopharma Holdings, Inc.、居里较为活跃，换手率分别为993.41%、242.88%、92.83%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Aspire Biopharma Holdings, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为50.85%、32.48%、30.40%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722534797a133a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722534797a133a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594152542","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594152542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594152542?lang=zh_cn&edition=full","pubTime":"2025-12-27 04:09","pubTimestamp":1766779768,"startTime":"0","endTime":"0","summary":"北京时间2025年12月27日04时09分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.04%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Can Fite Biopharma Ltd、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为996.62%、398.21%、161.74%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Briacell Therapeutics Corp C/Wts 26/02/2026、Cdt Equity Inc C/Wts 22/09/2028，振幅分别为97.83%、75.59%、54.26%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122704092897a0bf2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122704092897a0bf2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194783703","title":"Minerva Neurosciences：研发及管理成本可能上升，但我们有良好条件为Roluperidone在美国的第三阶段、NDA重新提交与上市准备提供资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1194783703","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194783703?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:36","pubTimestamp":1762346184,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences：研发及管理成本可能上升，但我们有良好条件为Roluperidone在美国的第三阶段、NDA重新提交与上市准备提供资金","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144077866","title":"Minerva Neurosciences：推动Roluperidone治疗精神分裂症负面症状的前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1144077866","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144077866?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:32","pubTimestamp":1762345934,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences：推动Roluperidone治疗精神分裂症负面症状的前景","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577322533","title":"Minerva Neurosciences, Inc盘中异动 大幅下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577322533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577322533?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:30","pubTimestamp":1761226224,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时30分，Minerva Neurosciences, Inc股票出现波动，股价急速下跌5.20%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ventyx Biosciences, Inc.、Ethzilla Corporation C/Wts 06/11/2025、Ibio, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ventyx Biosciences, Inc.、Ibio, Inc.较为活跃，换手率分别为145.33%、70.98%、57.46%，振幅较大的相关个股有Ventyx Biosciences, Inc.、Entero Therapeutics Inc.、Tango Therapeutics, Inc.，振幅分别为8.03%、7.08%、6.87%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321302594d9d1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321302594d9d1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1138956005","title":"Minerva Neurosciences股价在公司获得高达2亿美元的私人配售后大幅上涨，涨幅达163.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138956005","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138956005?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:38","pubTimestamp":1761053890,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences的股价在公司获得高达2亿美元的私人配售后涨幅超过两倍，最新涨幅为163.2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129991095","title":"Minerva Neurosciences- 进一步可能获得4000万美元收益，与按现金行使B系列认股权证有关，取决于达成里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1129991095","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129991095?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048191,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences- 进一步可能获得4000万美元收益，与按现金行使B系列认股权证有关，取决于达成里程碑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159095091","title":"Minerva Neurosciences将扩大董事会规模并任命最多三位董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1159095091","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159095091?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048189,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences将扩大董事会规模并任命最多三位董事","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140588980","title":"Minerva Neurosciences - 预计将获得足够资金以支持Roluperidone的确认性3期试验及向FDA重新提交NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1140588980","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140588980?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048187,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences - 预计将获得足够资金以支持Roluperidone的确认性3期试验及向FDA重新提交NDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186159233","title":"Minerva Neurosciences宣布融资最高达2亿美元以推进Roluperidone治疗精神分裂症患者的负面症状，进行三期确认试验，并重新提交新药申请，准备美国商业上市（如获批准）","url":"https://stock-news.laohu8.com/highlight/detail?id=1186159233","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186159233?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:01","pubTimestamp":1761048071,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences宣布融资最高达2亿美元，以推进Roluperidone治疗精神分裂症患者负面症状的三期确认试验，并重新提交新药申请，准备在美国上市（如获批准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2574176172","title":"Minerva Neurosciences, Inc盘中异动 早盘大幅下挫7.77%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574176172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574176172?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:32","pubTimestamp":1760016720,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时32分，Minerva Neurosciences, Inc股票出现波动，股价急速下挫7.77%。截至发稿，该股报2.61美元/股，成交量6.7083万股，换手率0.96%，振幅1.41%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Turn Therapeutics Inc.、Galecto, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Cdt Equity Inc.、Alaunos Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1618.06%、930.18%、635.88%，振幅较大的相关个股有Turn Therapeutics Inc.、Galecto, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为42.86%、22.06%、12.08%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213200a458601c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213200a458601c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518003352","title":"Minerva Neurosciences, Inc盘中异动 大幅跳水6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518003352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518003352?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:15","pubTimestamp":1741634146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时15分，Minerva Neurosciences, Inc股票出现波动，股价急速下跌6.10%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6302.04%、3861.36%、1023.87%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517369928","title":"Minerva Neurosciences, Inc盘中异动 快速上涨5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517369928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517369928?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:17","pubTimestamp":1741198670,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时17分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.06%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为948.37%、305.84%、301.30%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516753670","title":"Minerva Neurosciences, Inc盘中异动 急速下挫7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516753670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516753670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:53","pubTimestamp":1741099982,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时53分，Minerva Neurosciences, Inc股票出现异动，股价大幅跳水7.19%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1138.13%、1114.47%、515.66%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Nutriband Inc C/Wts ，振幅分别为44.32%、37.67%、25.66%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516552277","title":"Minerva Neurosciences, Inc2024财年实现净利润1.44百万美元，同比增加104.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552277?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844851,"startTime":"0","endTime":"0","summary":"3月2日，Minerva Neurosciences, Inc公布财报，公告显示公司2024财年净利润为1.44百万美元，同比增加104.80%；其中营业收入为0.00美元，每股基本收益为0.19美元。从资产负债表来看，Minerva Neurosciences, Inc总负债62.84百万美元，其中短期债务0.00美元，资产负债比为0.60，流动比率为7.85。机构评级：截至2025年3月2日，当前有1家机构对Minerva Neurosciences, Inc目标价做出预测，其中目标均价为5.00美元，其中最低目标价为5.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193483570","title":"Minerva Neurosciences 2024年第四季度GAAP每股收益$(0.56)优于预期的$(1.05)，截至2024年12月31日现金、现金等价物和受限制现金约为$21.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=1193483570","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193483570?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:50","pubTimestamp":1740487840,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences 报告季度亏损每股$，优于分析师一致预期的每股亏损$，超出达46.67%。相比去年同期每股亏损$，这是增长了52.94%。以上内容来自Benzinga Earnings专栏，原文如下：$Minerva Neurosciences$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 46.67 percent. This is a 52.94 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Minerva Neurosciences 2024年第四季度GAAP每股收益$(0.56)优于预期的$(1.05)，截至2024年12月31日现金、现金等价物和受限制现金约为$21.5M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minervaneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0321},{"period":"1month","weight":-0.3225},{"period":"3month","weight":0.1532},{"period":"6month","weight":1.3064},{"period":"1year","weight":2.8993},{"period":"ytd","weight":0.3483}],"compareEarnings":[{"period":"1week","weight":0.0317},{"period":"1month","weight":-0.0033},{"period":"3month","weight":-0.0196},{"period":"6month","weight":0.0352},{"period":"1year","weight":0.3616},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Minerva Neurosciences, Inc.于2007年4月23日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化中枢神经系统疾病的专利候选产品。其主要候选药物罗鲁哌酮正在开发中，用于治疗精神分裂症的阴性症状，计划进行3期确认性试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.082044},{"month":2,"riseRate":0.25,"avgChangeRate":-0.062323},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.006398},{"month":4,"riseRate":0.416667,"avgChangeRate":0.03757},{"month":5,"riseRate":0.545455,"avgChangeRate":0.1467},{"month":6,"riseRate":0.636364,"avgChangeRate":0.069702},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.035509},{"month":8,"riseRate":0.5,"avgChangeRate":0.304921},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003875},{"month":10,"riseRate":0.25,"avgChangeRate":-0.122814},{"month":11,"riseRate":0.5,"avgChangeRate":0.078313},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.079275}],"exchange":"NASDAQ","name":"Minerva Neurosciences","nameEN":"Minerva Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Minerva Neurosciences,NERV,Minerva Neurosciences股票,Minerva Neurosciences股票老虎,Minerva Neurosciences股票老虎国际,Minerva Neurosciences行情,Minerva Neurosciences股票行情,Minerva Neurosciences股价,Minerva Neurosciences股市,Minerva Neurosciences股票价格,Minerva Neurosciences股票交易,Minerva Neurosciences股票购买,Minerva Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}